Sponsor or institution
Clinical trials and research at Cardurion Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Cardurion Pharmaceuticals, Inc. that are recruiting, at sites in 6 countries (most in United States (2), Canada (1), France (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
CRD-4730 for heart failure with reduced ejection fraction
This trial tests CRD-4730 versus placebo to see if it helps adults with HFrEF who are already on standard heart failure therapy.
-
Phase 2 test of CRD-4730 for Catecholaminergic Polymorphic Ventricular Tachycardia
This trial will test whether two doses of the experimental drug CRD-4730 are safe and affect exercise-induced dangerous heart rhythms in adults with CPVT.
Quick answers
How many clinical trials run by Cardurion Pharmaceuticals, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Canada (1 trial), France (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.